BioSpace News Archive

The computed tomography market has been anticipated to experience numerous growth opportunities in the foreseeable years.

The 3D Cell Culture Market revenues surpassed US$ 1.15 Billion in 2022, as per a new FMI study.

The advancements in wide-field imaging continues to be a boon for medical practitioners and patients alike.

Modern day medical treatments are highly dependent advanced technological development and innovation taking place in the healthcare sector.

Sequana Medical NV announces its financial results for the year ended 31 December 2021, and provides a business update and an outlook for the remainder of 2022.

Captor Therapeutics S.A. announces the molecular targets of one of its core pipeline projects designated CT-01, which is focused on the development of TPD therapy for hepatocellular carcinoma.

Acer Therapeutics Inc. and its collaboration partner, Relief Therapeutics Holding SA, announced the presentation of data evaluating the bioavailability, bioequivalence and taste attributes of taste-masked sodium phenylbutyrate compared to sodium phenylbutyrate ) powder during poster sessions at the recent Society for Inherited Metabolic Disorders Annual Meeting on April 10-13, 2022 in Orlando, Florida.

Engitix Ltd, a biotechnology company developing a portfolio of programmes in fibrosis and solid tumours using its proprietary human extracellular matrix platform, entered into an agreement with Takeda to expand an existing collaboration to now include the discovery and development of novel therapeutics for fibrostenotic inflammatory bowel disease, including Crohn’s disease and ulcerative colitis.

Devyser announces a strengthening of its commercial organization with the appointment of Theis Kipling as Chief Commercial Officer with global responsibility for sales, marketing, product management and tech support.

Allelica, a leading genomics software company that develops digital tools to develop, validate and calculate polygenic risk scores for common diseases, is teaming with Thomas Fernandez, MD of Yale School of Medicine in a research project aimed at uncovering the genetic basis for multiple childhood neuropsychiatric disorders.